(Q43285992)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707803%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Serum-protein interactions with anticancer Ru(III) complexes KP1019 and KP418 characterized by EPR (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707803%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

ChEBI release 2020-05-28

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707803%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Naniye Cetinbas

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707803%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Michael I Webb

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707803%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Charles J Walsby

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707803%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

1 reference

26 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707803%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Inorganic Chemistry

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707803%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707803%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707803%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

131-145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707803%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00775-009-0578-5

6 February 2020

exact match

0 references

cites work

The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00775-009-0578-5

From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).

21 January 2018

1 reference

12 December 2020

Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.

1 reference

12 December 2020

Capillary electrophoresis hyphenated to inductively coupled plasma-mass spectrometry: a novel approach for the analysis of anticancer metallodrugs in human serum and plasma

1 reference

12 December 2020

Antitumor activity of some ruthenium derivatives in human colon cancer cell lines in vitro

1 reference

12 December 2020

Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media

1 reference

12 December 2020

XSophe-Sophe-XeprView. A computer simulation software suite (v. 1.1.3) for the analysis of continuous wave EPR spectra.

1 reference

12 December 2020

Mutational analysis of C-lobe ligands of human serum transferrin: insights into the mechanism of iron release

1 reference

12 December 2020

Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and anti

1 reference

12 December 2020

Metal-based antitumour drugs in the post genomic era.

1 reference

12 December 2020

1 reference

12 December 2020

Further characterization of specific drug binding sites on human serum albumin

1 reference

12 December 2020

Biological role of adduct formation of the ruthenium(III) complex NAMI-A with serum albumin and serum transferrin.

1 reference

12 December 2020

Synthesis, Characterization and Solution Chemistry of trans-Indazoliumtetrachlorobis(Indazole)Ruthenate(III), a New Anticancer Ruthenium Complex. IR, UV, NMR, HPLC Investigations and Antitumor Activity. Crystal Structures of trans-1-Methyl-Indazoliu

1 reference

12 December 2020

Preclinical activity of trans-indazolium[tetrachlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cells

1 reference

12 December 2020

Synthesis and reactivity of the aquation product of the antitumor complex trans-[Ru(III)Cl4(indazole)2]-.

1 reference

12 December 2020

Hydrolysis of the tumor-inhibiting ruthenium(III) complexes HIm trans-[RuCl4(im)2] and HInd trans-[RuCl4(ind)2] investigated by means of HPCE and HPLC-MS.

1 reference

12 December 2020

Comparative nephrotoxicity of some antitumour-active platinum and ruthenium complexes in rats

1 reference

12 December 2020

Comparative binding of antitumor indazolium [trans-tetrachlorobis(1H-indazole)ruthenate(III)] to serum transport proteins assayed by capillary zone electrophoresis

1 reference

12 December 2020

Ruthenium complexes as anticancer agents

1 reference

12 December 2020

Redox-active antineoplastic ruthenium complexes with indazole: correlation of in vitro potency and reduction potential

1 reference

12 December 2020

Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology.

1 reference

12 December 2020

The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation

1 reference

12 December 2020

The heterocyclic ruthenium(III) complex KP1019 (FFC14A) causes DNA damage and oxidative stress in colorectal tumor cells.

1 reference

12 December 2020

Differences in structure, physiological stability, electrochemistry, cytotoxicity, DNA and protein binding properties between two Ru(III) complexes.

1 reference

12 December 2020

Synergistic antitumor interactions between newly synthesized ruthenium complexes and cytokines in human colon carcinoma cell lines

1 reference

12 December 2020

1H NMR, EPR, UV-Vis, and Electrochemical Studies of Imidazole Complexes of Ru(III). Crystal Structures of cis-[(Im)(2)(NH(3))(4)Ru(III)]Br(3) and [(1MeIm)(6)Ru(II)]Cl(2).2H(2)O

1 reference

12 December 2020

Albumin: biochemical properties and therapeutic potential

1 reference

12 December 2020

In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer

1 reference

12 December 2020

Cytotoxicity of the organic ruthenium anticancer drug Nami-A is correlated with DNA binding in four different human tumor cell lines

1 reference

12 December 2020

Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study

1 reference

12 December 2020

The binding properties of two antitumor ruthenium(III) complexes to apotransferrin

1 reference

12 December 2020

Crystal structural analysis of human serum albumin complexed with hemin and fatty acid

1 reference

12 December 2020

Structure-function relationships within Keppler-type antitumor ruthenium(III) complexes: the case of 2-aminothiazolium[trans-tetrachlorobis(2-aminothiazole)ruthenate(III)].

1 reference

12 December 2020

CZE-ICP-MS as a tool for studying the hydrolysis of ruthenium anticancer drug candidates and their reactivity towards the DNA model compound dGMP.

1 reference

12 December 2020

Solvolysis of the Tumor-Inhibiting Ru(III)-Complex trans-Tetrachlorobis(Indazole)Ruthenate(III).

1 reference

12 December 2020

Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells.

1 reference

12 December 2020

Effect of protein concentration on the binding of gold(I) to human serum albumin

1 reference

12 December 2020

The characterization of two specific drug binding sites on human serum albumin

1 reference

12 December 2020

A comparative study of adduct formation between the anticancer ruthenium(III) compound HInd trans-[RuCl4(Ind)2] and serum proteins.

1 reference

12 December 2020

Studies on the interactions between human serum albumin and trans-indazolium (bisindazole) tetrachlororuthenate(III).

1 reference

12 December 2020

Rapid adiabatic passage EPR of ferricytochrome c: signal enhancement and determination of the spin-lattice relaxation time.

1 reference

12 December 2020

Steroid binding to human serum albumin and fragments thereof. Role of protein conformation and fatty acid content

1 reference

12 December 2020

Comparison of the Antiproliferative Activity of Two Antitumour Ruthenium(III) Complexes With Their Apotransferrin and Transferrin-Bound Forms in a Human Colon Cancer Cell Line.

1 reference

12 December 2020

Ruthenium antimetastatic agents

1 reference

12 December 2020

Redox behavior of tumor-inhibiting ruthenium(iii) complexes and effects of physiological reductants on their binding to GMP

1 reference

12 December 2020

The reduction of (ImH)[trans-RuIIICl4(dmso)(Im)] under physiological conditions: preferential reaction of the reduced complex with human serum albumin.

1 reference

12 December 2020

Appraisal of the redox behaviour of the antimetastatic ruthenium(III) complex [ImH][RuCl(4)(DMSO)(Im)], NAMI-A.

1 reference

12 December 2020

Non-platinum chemotherapeutic metallopharmaceuticals

1 reference

12 December 2020

Investigations into the interaction between tumor-inhibiting ruthenium(III) complexes and nucleotides by capillary electrophoresis.

1 reference

12 December 2020

Studies on the interactions between human serum albumin and imidazolium [trans-tetrachlorobis(imidazol)ruthenate(III)].

1 reference

12 December 2020

Recent developments in the field of tumor-inhibiting metal complexes.

1 reference

12 December 2020

Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A.

1 reference

12 December 2020

Protein-binding Properties of two Antitumour Ru(III) Complexes to Human Apotransferrin and Apolactoferrin

1 reference

12 December 2020

Distribution of iron between the binding sites of transferrin in serum: methods and results in normal human subjects

1 reference

12 December 2020

Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action

1 reference

12 December 2020

Ruthenium Anticancer Compounds: Challenges and Expectations

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.2533/CHIMIA.2007.692

10.1007/S00775-009-0578-5

8 July 2023

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19707803%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference